Richard Goldberg, a gastrointestinal cancer expert, was named the new director of the WVU Cancer Institute.
Justin Klamerus was appointed to president of the Barbara Ann Karmanos Cancer Hospital, the clinical operation of Karmanos Cancer Institute.
Maria Werner-Wasik was named executive vice chair for radiation oncology integration and the Walter Curran Professor of Radiation Oncology.
Northwell Health announced collaboration with Indivumed to speed the advance of precision cancer research.
Tempus, a technology company focused on helping doctors personalize cancer care, and University Hospitals Seidman Cancer Center joined together to improve research and healthcare by making genomic data, advanced molecular analysis and clinical decision support tools available to the hospital's researchers, physicians and healthcare providers.
The Society of Thoracic Surgeons released the first publicly accessible national report of outcomes from lobectomy, a lung cancer procedure that removes a portion of the lung.
A phase II study of abemaciclib, a cyclin-dependent kinase 4 and CDK 6 inhibitor, met its primary endpoint of reducing expression of Ki67, a biomarker of cell proliferation, after two weeks of treatment.
NCI CTEP approved the following clinical research studies last month. For further information, contact the principal investigator listed.
A new study by Geisinger Health System physicians reports that the use of opioid therapy to treat chronic pain is not only ineffective, it can actually increase the likelihood of more harmful consequences, including death.
Head and neck cancer patients with evidence of human papillomavirus infection generally have a better prognosis than people without evidence of infection.
